Xtx Topco LTD Compugen LTD Transaction History

Xtx Topco LTD

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$0.53 - $2.0 $2,390 - $9,020	4,510 Added 24.48%	22,936 $45,000
Q3 2023 Nov 13, 2023	BUY	$0.88 - $1.31 $16,214 - $24,138	18,426 New	18,426 $17,000
Q3 2022 Nov 14, 2022	BUY	$0.66 - $2.32 $168,681 - $592,940	255,578 Added 2335.33%	266,522 $175,000
Q2 2022 Aug 15, 2022	SELL	$1.57 - $3.33 $53,339 - $113,133	-33,974 Reduced 75.64%	10,944 $20,000
Q1 2022 May 13, 2022	BUY	$2.76 - $4.64 $23,777 - $39,973	8,615 Added 23.73%	44,918 $145,000
Q4 2021 Feb 11, 2022	BUY	$4.09 - $7.16 $89,857 - $157,305	21,970 Added 153.28%	36,303 $156,000
Q3 2021 Nov 12, 2021	BUY	$5.8 - $8.02 $83,131 - $114,950	14,333 New	14,333 $86,000

13.1M

79.2K

12.7K

Ticker CGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,624,600
Market Cap $131M
Description
Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tu...

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

Stay updated on Xtx Topco LTD with notifications on news.